1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cell Line Development Serum Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cell Line Development Serum Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cell Line Development Serum Market Regional Analysis
6.2 North America Cell Line Development Serum Market Revenue 2017-2027 (US$ Million)
6.3 North America Cell Line Development Serum Market Forecast Analysis
7. North America Cell Line Development Serum Market Analysis – by Type
7.1 Fetal Bovine Serum
- 7.1.1 Overview
- 7.1.2 Fetal Bovine Serum: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Adult Bovine Serum
- 7.2.1 Overview
- 7.2.2 Adult Bovine Serum: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Porcine Serum
- 7.3.1 Overview
- 7.3.2 Porcine Serum: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Horse Serum
- 7.4.1 Overview
- 7.4.2 Horse Serum: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Other Animal Serum
- 7.5.1 Overview
- 7.5.2 Other Animal Serum: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Cell Line Development Serum Market Analysis – by Application
8.1 Bioproduction
- 8.1.1 Overview
- 8.1.2 Bioproduction: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Drug Discovery
- 8.2.1 Overview
- 8.2.2 Drug Discovery: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.3 Tissue Engineering and Regenerative Medicines
- 8.3.1 Overview
- 8.3.2 Tissue Engineering and Regenerative Medicines: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.4 Toxicity Testing
- 8.4.1 Overview
- 8.4.2 Toxicity Testing: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.5 Academic Research
- 8.5.1 Overview
- 8.5.2 Academic Research: North America Cell Line Development Serum Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Cell Line Development Serum Market – North America Analysis
9.1 Overview
9.2 North America
- 9.2.1 North America Cell Line Development Serum Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 North America Cell Line Development Serum Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 US:
North America Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 US: North America Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.1.2 US: North America Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.2 Canada:
North America Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 Canada: North America Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.2.2 Canada: North America Cell Line Development Serum Market Breakdown, by Application
- 9.2.1.3 Mexico :
North America Cell Line Development Serum Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Mexico : North America Cell Line Development Serum Market Breakdown, by Type
- 9.2.1.3.2 Mexico : North America Cell Line Development Serum Market Breakdown, by Application
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Lonza
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc.
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Sigma-Aldrich Corporation (Merck KGaA)
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Cytiva (Danaher)
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Corning Incorporated
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 European Collection of Cell Cultures (ECACC)
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 WuXi AppTec
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 American Type Culture Collection (ATCC)
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For North America Cell Line Development Serum Market
